A Biologically Informed Vision-Guided Framework for Interpretable T Cell Receptor-Epitope Binding Prediction

Yajing Yuan1, Junwei Chen1, Yufang Zhang2

  • 1State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200040, P. R. China.

Insights

A new deep learning framework, DAISY, accurately predicts T-cell receptor (TCR) and epitope binding for cancer immunotherapy. It outperforms existing models by integrating physicochemical properties, aiding in predicting patient survival and advancing immune modeling.

Area of Science:

  • Immunology
  • Computational Biology
  • Bioinformatics

Background:

  • Accurate prediction of T-cell receptor (TCR)-epitope binding is crucial for cancer immunotherapy.
  • Current predictive models face challenges in generalization and incorporating key physicochemical properties.

Purpose of the Study:

  • To propose DAISY, a biologically informed, vision-guided deep learning framework for robust and interpretable TCR-epitope binding prediction.
  • To improve generalization to unseen epitopes and integrate physicochemical properties.

Main Methods:

  • DAISY integrates hierarchical physicochemical features using a Condition-Adaptive Fusion module.
  • It models residue-level spatial interactions and global biochemical context.
  • Score-CAM visualizations provide interpretability by localizing interaction-relevant residues.

Main Results:

  • DAISY consistently outperforms state-of-the-art models across four generalization scenarios.
  • It achieved an 11% improvement in ROC-AUC and a 16% improvement in PR-AUC in the Unseen-Pair setting.
  • Predictions correlate with T-cell clonal expansion, functional TCR identification, and patient survival forecasting.

Conclusions:

  • DAISY offers a powerful tool for translational immunology and immune modeling.
  • It provides a scalable paradigm for next-generation immune modeling.
  • The framework enhances the prediction of TCR-epitope interactions for immunotherapy applications.